The Chemours Company
CC
$16.77
-$1.22-6.78%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -659.42% | -634.92% | -504.72% | 103.34% | 128.99% |
| Total Depreciation and Amortization | 16.44% | 6.16% | 3.05% | -0.33% | -4.89% |
| Total Amortization of Deferred Charges | -8.33% | 0.00% | 9.09% | 20.00% | 33.33% |
| Total Other Non-Cash Items | 656.25% | 145.28% | 266.67% | 141.42% | 111.27% |
| Change in Net Operating Assets | 117.42% | 121.16% | 130.42% | -246.11% | -264.84% |
| Cash from Operations | 141.71% | 191.70% | 186.87% | -216.67% | -213.85% |
| Capital Expenditure | 40.83% | 28.24% | 21.21% | 10.24% | 2.70% |
| Sale of Property, Plant, and Equipment | 133.33% | 105.38% | -87.50% | -100.00% | -40.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -85.71% | 100.00% | 300.00% |
| Cash from Investing | 41.64% | 28.19% | -27.57% | -45.06% | -54.15% |
| Total Debt Issued | 18.45% | 559.17% | 2.98% | -9.81% | -9.34% |
| Total Debt Repaid | -47.19% | -471.54% | -80.26% | -52.90% | -59.79% |
| Issuance of Common Stock | -- | -88.89% | -94.44% | -55.56% | -52.63% |
| Repurchase of Common Stock | 66.67% | 75.00% | 95.45% | 96.55% | 96.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 47.30% | 33.56% | 16.22% | 0.67% | 0.67% |
| Other Financing Activities | 27.27% | -66.67% | 275.00% | 466.67% | 466.67% |
| Cash from Financing | -250.00% | 96.83% | -111.56% | -120.97% | -120.93% |
| Foreign Exchange rate Adjustments | 231.82% | -20.00% | 209.09% | 36.36% | -650.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.26% | 99.87% | 79.75% | -352.71% | -307.55% |